JAMA Pediatrics
Original Investigation
May 1, 2017
Anne M. Neilan, MD, MPH; Brad Karalius, MPH; Kunjal Patel, DSc, MPH; Russell B. Van Dyke, MD; Mark J. Abzug, MD; Allison L. Agwu, MD, ScM; Paige L. Williams, PhD; Murli Purswani, MD; Deborah Kacanek, ScD; James M. Oleske, MD, MPH; Sandra K. Burchett, MD, MSc; Andrew Wiznia, MD; Miriam Chernoff, PhD; George R. Seage III, DSc, MPH; Andrea L. Ciaranello, MD, MPH; for the Pediatric HIV /AIDS Cohort Study and the International Maternal Adolescent and Pediatric AIDS Clinical Trials Network
free access
JAMA Pediatr. 2017; 171(5):450-460. doi: 10.1001/jamapediatrics.2017.0141This study examines the incidence or first occurrence during follow-up of key clinical events and mortality among perinatally HIV-infected youth stratified by age, CD4 cell count, and viral load and antiretroviral status.
JAMA Network Open
Original Investigation
Public Health
December 18, 2019
Kathleen M. Powis, MD, MBA, MPH; Yanling Huo, MS; Paige L. Williams, PhD; Deborah Kacanek, ScD; Jennifer Jao, MD, MPH; Kunjal Patel, DSc, MPH; George R. Seage III, DSc, MPH; Russell B. Van Dyke, MD; Ellen G. Chadwick, MD; for the Pediatric HIV /AIDS Cohort Study (PHACS)
open access
JAMA Netw Open. 2019; 2(12):e1917669. doi: 10.1001/jamanetworkopen.2019.17669This cohort study compares antiretroviral prescribing practices over time among pregnant women living with HIV with US Department of Health and Human Services treatment guidelines.
JAMA Pediatrics
Original Investigation
January 1, 2015
Paige L. Williams, PhD; Marilyn J. Crain, MD; Cenk Yildirim, MS; Rohan Hazra, MD; Russell B. Van Dyke, MD; Kenneth Rich, MD; Jennifer S. Read, MD; Emma Stuard, MD; Mobeen Rathore, MD; Hermann A. Mendez, MD; D. Heather Watts, MD; for the Pediatric HIV /AIDS Cohort Study
free access
JAMA Pediatr. 2015; 169(1):48-55. doi: 10.1001/jamapediatrics.2014.1889This prospective cohort study finds that few individual antiretrovirals and no drug classes were associated with an increased risk of congenital anomalies in HIV-exposed infants after adjustment for calendar year and maternal characteristics.
JAMA Pediatrics
Original Investigation
December 1, 2014
Deborah Persaud, MD; Kunjal Patel, DSc, MPH; Brad Karalius, MPH; Kaitlin Rainwater-Lovett, PhD, MPH; Carrie Ziemniak, MS; Angela Ellis, BS; Ya Hui Chen, BA; Douglas Richman, MD; George K. Siberry, MD, MPH; Russell B. Van Dyke, MD; Sandra Burchett, MD; George R. Seage III, DSc, MPH; Katherine Luzuriaga, MD; for the Pediatric HIV /AIDS Cohort Study
free access
JAMA Pediatr. 2014; 168(12):1138-1146. doi: 10.1001/jamapediatrics.2014.1560This cross-sectional study associates early effective combination antiretroviral therapy with prolonged virologic suppression after perinatal human immunodeficiency virus infection, leading to negligible peripheral blood proviral reservoirs.
JAMA Pediatrics
Article
June 1, 2013
Steven E. Lipshultz, MD; Paige L. Williams, PhD; James D. Wilkinson, MD, MPH; Erin C. Leister, MS; Russell B. Van Dyke, MD; William T. Shearer, MD, PhD; Kenneth C. Rich, MD; Rohan Hazra, MD; Jonathan R. Kaltman, MD; Denise L. Jacobson, PhD; Laurie B. Dooley, MT, MBA; Gwendolyn B. Scott, MD; Nicole Rabideau, RDCS; Steven D. Colan, MD; for the Pediatric HIV /AIDS Cohort Study (PHACS)
free access
JAMA Pediatr. 2013; 167(6):520-527. doi: 10.1001/jamapediatrics.2013.1206In the National Institutes of Health–funded Pediatric HIV/AIDS Cohort Study’s Adolescent Master Protocol, Lipshultz and coauthors used linear regression models to compare echocardiographic measures to determine the cardiac effects of prolonged exposure to highly active antiretroviral therapy on children infected with human immunodeficiency virus (HIV).
JAMA Pediatrics
Article
August 1, 2011
Peter Freeman, MPH; Bendu C. Walker, MPH; D. Robert Harris, PhD; Robert Garofalo, MD; Nancy Willard, MS; Jonathan M. Ellen, MD; for the Adolescent Trials Network for HIV /AIDS Interventions 016b Team
free access
Arch Pediatr Adolesc Med. 2011; 165(8):736-740. doi: 10.1001/archpediatrics.2011.118
JAMA Pediatrics
Article
March 1, 2010
William Barnes, PhD; Lawrence D’Angelo, MD; Michiyo Yamazaki, PhD; Marvin Belzer, MD; Sybil Schroeder, PhD; Judith Palmer-Castor, PhD; Donna Futterman, MD; Bill Kapogiannis, MD; Larry Muenz, PhD; D. Robert Harris, PhD; Jonathan M. Ellen, MD; Adolescent Trials Network for HIV /AIDS Interventions
free access
Arch Pediatr Adolesc Med. 2010; 164(3):273-276. doi: 10.1001/archpediatrics.2009.278
JAMA
Original Contribution
July 12, 2000
Maurizio de Martino, MD; Pier-Angelo Tovo, MD; Maria Balducci, DMath; Luisa Galli, MD; Clara Gabiano, MD; Giovanni Rezza, MD; Patrizio Pezzotti, DStat; for the Italian Register for HIV Infection in Children and the Italian
National AIDS Registry
free access
JAMA. 2000; 284(2):190-197. doi: 10.1001/jama.284.2.190
JAMA Dermatology
Study
November 1, 2006
Ulrike Wieland, MD; Norbert H. Brockmeyer, MD; Soenke J. Weissenborn, PhD; Bettina Hochdorfer, MD; Markus Stücker, MD; Jochen Swoboda, MD; Peter Altmeyer, MD; Herbert Pfister, PhD; Alexander Kreuter, MD; for the Competence Network HIV /AIDS
free access
Arch Dermatol. 2006; 142(11):1438-1444. doi: 10.1001/archderm.142.11.1438
JAMA Pediatrics
Article
March 1, 2003
Debra A. Murphy, PhD; Moussa Sarr, MD, MPH; Stephen J. Durako; Anna-Barbara Moscicki, MD; Craig M. Wilson, MD; Larry R. Muenz, PhD; for the Adolescent Medicine HIV /AIDS Research Network
free access
Arch Pediatr Adolesc Med. 2003; 157(3):249-255. doi: 10.1001/archpedi.157.3.249
JAMA Pediatrics
Article
Journal Club
April 1, 2011
Deborah Koniak-Griffin, EdD, RNC; Janna Lesser, PhD, RN; Sumiko Takayanagi, PhD; William G. Cumberland, PhD
free access
Arch Pediatr Adolesc Med. 2011; 165(4):306-312. doi: 10.1001/archpediatrics.2011.28
JAMA Network Open
Original Investigation
Global Health
January 22, 2021
Fan Yang, PhD; Zhihui Li, ScD; S. V. Subramanian, PhD; Chunling Lu, PhD
open access
JAMA Netw Open. 2021; 4(1):e2035000. doi: 10.1001/jamanetworkopen.2020.35000This cross-sectional study provides an up-to-date assessment of the levels of and changes in knowledge of HIV/AIDs and its association with socioeconomic disparity among young women in low- and middle-income countries.
JAMA Network Open
September 13, 2019
JAMA Network Open
Original Investigation
Infectious Diseases
February 3, 2021
James M. Tesoriero, PhD; Carol-Ann E. Swain, PhD; Jennifer L. Pierce, BS; Lucila Zamboni, PhD; Meng Wu, PhD; David R. Holtgrave, PhD; Charles J. Gonzalez, MD; Tomoko Udo, PhD; Johanne E. Morne, MS; Rachel Hart-Malloy, PhD; Deepa T. Rajulu, MS; Shu-Yin John Leung, MA; Eli S. Rosenberg, PhD
open access is active quiz
JAMA Netw Open. 2021; 4(2):e2037069. doi: 10.1001/jamanetworkopen.2020.37069This cohort study evaluates the association between HIV diagnosis and coronavirus disease 2019 diagnosis, hospitalization, and in-hospital death in New York State.
JAMA
US Preventive Services Task Force
Recommendation Statement
June 18, 2019
US Preventive Services Task Force
free access is active quiz has multimedia
JAMA. 2019; 321(23):2326-2336. doi: 10.1001/jama.2019.6587This 2019 Recommendation Statement from the US Preventive Services Task Force recommends screening for HIV infection in adolescents and adults aged 15 to 65 years and in younger adolescents and older adults at increased risk of infection (A recommendation) and in all pregnant persons, including those with unknown HIV status at labor or delivery (A recommendation).
JAMA Network Open
September 13, 2019
JAMA Dermatology
From the MMWR
January 1, 2003
Arch Dermatol. 2003; 139(1):109-110. doi: 10.1001/archderm.139.1.109
JAMA
Special Communication
October 27, 2020
Michael S. Saag, MD; Rajesh T. Gandhi, MD; Jennifer F. Hoy, MBBS; Raphael J. Landovitz, MD; Melanie A. Thompson, MD; Paul E. Sax, MD; Davey M. Smith, MD; Constance A. Benson, MD; Susan P. Buchbinder, MD; Carlos del Rio, MD; Joseph J. Eron Jr, MD; Gerd Fätkenheuer, MD; Huldrych F. Günthard, MD; Jean-Michel Molina, MD; Donna M. Jacobsen, BS; Paul A. Volberding, MD
is active quiz
JAMA. 2020; 324(16):1651-1669. doi: 10.1001/jama.2020.17025This guideline from the International Antiviral (formerly AIDS) Society–USA updates practice recommendations for managing HIV infection including when to initiate antiviral therapy, how to monitor patients’ response, when to change antiviral regimens, and use of preexposure prophylaxis (PrEP) to prevent infection in those at risk.
JAMA Network Open
Original Investigation
Public Health
September 13, 2019
Dale A. Barnhart, ScD; Isaac Tsikhutsu, MMed; Duncan Kirui, BSc; Fredrick Sawe, MMed; Jane Muli, BSN; William Sugut, KRCHN; Nareen Abboud, PhD; Deborah Birx, MD; Tiffany Hamm, PhD; Peter Coakley, MD; Patrick W. Hickey, MD; Vanessa Wolfman, MD; Elizabeth Lee, DrPH; Donna Spiegelman, ScD
open access
JAMA Netw Open. 2019; 2(9):e1911318. doi: 10.1001/jamanetworkopen.2019.11318This population-based survey study examines the extent to which the decrease in child mortality in Kenya is associated with the US President’s Emergency Plan for AIDS Relief (PEPFAR) funding for prevention of mother-to-child transmission of HIV.